// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE AFTER RADICAL OR PARTIAL NEPHRECTOMY FOR T1A RENAL CELL CARCINOMA: A POPULATION-BASED STUDY

Madhur Nayan - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Microvascular complications of diabetes 1

N/A

THE KIDNEY THAT WASN'T

Anne-Sophie Blais - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

TESTICULAR SPERM ASPIRATION IN MEN WITH SEVERE OLIGOZOOSPERMIA AND CRYPTOZOOSPERMIA: SPERM RETRIEVAL RATES AND ICSI OUTCOMES

Mohannad Alharbi - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE EFFECT OF ANNUAL HOSPITAL VOLUME (AHV) ON PERIOPERATIVE OUTCOMES AFTER URETHROPLASTY

Marco Bandini - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Urinary tract infections

N/A

URETHRAL STRICTURE IS FREQUENTLY A MORBID CONDITION: IDENTIFYING PATIENTS AT INCREASED RISK FOR COMPLICATIONS DUE TO URETHRAL STRICTURE

Christopher King - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Renal insufficiency

N/A

COMPREHENSIVE PROSPECTIVE ASSESSMENT OF PATIENT REPORTED OUTCOMES AFTER URETHROPLASTY

Jordan Bekkema - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Male Sexual Dysfunction

N/A

THE EVOLUTION OF URETHRAL STRICTURE TREATMENT OVER 15 YEARS: A SINGLE-CENTRE, SINGLE-SURGEON 1319 URETHROPLASTY ANALYSIS

R. Christopher Doiron - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

PD-1/PD-L1 IMMUNE-CHECKPOINT INHIBITION WITH RADIATION IN BLADDER CANCER: IN SITU AND ABSCOPAL EFFECTS

Alexis Rompré-Brodeur - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Bladder Cancer

N/A

IMPROVING QUALITY OF PROSTATE CANCER SURGERY BY PROVIDING FEEDBACK TO SURGEONS: THE SURGICAL REPORT CARD (SUREP) STUDY

Ravi M. Kumar - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

IMPACT OF TIME-TO-SURGERY AND SURGICAL DELAY ON ONCOLOGIC OUTCOMES FOR RENAL CELL CARCINOMA

Benjamin Shiff - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

N/A

LONG TERM FUNCTIONAL OUTCOMES AND COMPLICATIONS OF STUDER ORTHOTOPIC NEOBLADDER

Ernest Chan - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DETRUSOR RELAXATION MEDIATED BY ACTIVATION OF THE SUCCINATE RECEPTOR GPR91.

Abubakr Mossa - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nitric oxide

MUSCARINIC RECEPTOR EXPRESSION IN SPINAL CORD TRANSECTED RATS WITH EARLY ANTICHOLINERGIC TREATMENT

George Loutochin - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ASSESSING THE METHODOLOGICAL AND REPORTING QUALITY OF CLINICAL SYSTEMATIC REVIEWS AND META-ANALYSES IN PAEDIATRIC UROLOGY: CAN WE BUILD PRACTICES ON CONTEMPORARY HIGHEST LEVELS OF EVIDENCE?

Fardod O'Kelly - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A RANDOMIZED CONTROLLED TRIAL OF A MODIFIED CYSTOSCOPY TECHNIQUE TO DECREASE PATIENT’S PAIN AND ANXIETY

Khalil Hetou - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

VOIDING CYSTROURETHROGRAMS FOR INFANTS WITH ISOLATED HIGH-GRADE PRENATAL HYDRONEPHROSIS AND HYDROURETERONEPHROSIS WITHOUT A HISTORY OF PREVIOUS UTI: IS IT REALLY NECESSARY?

George Goucher - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Urinary tract infections

N/A

REVISITING RISK FACTORS FOR FEBRILE URINARY TRACT INFECTION USING A LARGE PRENATAL HYDRONEPHROSIS DATASET

Luis H. Braga - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Urinary tract infections

N/A

XENOBIOTIC METABOLISM OF ABIRATERONE ACETATE AND GLUCOCORTICOIDS BY THE GUT MICROBIOTA

Kamilah Abdur-Rashid - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

CB-7598

RENAL HYPOTHERMIA DURING PARTIAL NEPHRECTOMY: A RANDOMIZED CONTROLLED TRIAL

Rodney Breau - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER

Scott Eggener - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Prostate cancer

N/A

Copyright © 2026. QuantiNova All rights reserved